Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,710 | 24 | 80.1% |
| Consulting Fee | $425.00 | 1 | 19.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $1,166 | 15 | $0 (2023) |
| PFIZER INC. | $571.48 | 3 | $0 (2019) |
| ViiV Healthcare Company | $125.00 | 1 | $0 (2024) |
| DePuy Synthes Sales Inc. | $103.53 | 2 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $100.00 | 1 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $49.54 | 2 | $0 (2021) |
| Allergan Inc. | $19.52 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $125.00 | 1 | ViiV Healthcare Company ($125.00) |
| 2023 | $132.63 | 1 | E.R. Squibb & Sons, L.L.C. ($132.63) |
| 2022 | $268.89 | 3 | E.R. Squibb & Sons, L.L.C. ($268.89) |
| 2021 | $132.34 | 2 | E.R. Squibb & Sons, L.L.C. ($112.68) |
| 2020 | $29.88 | 1 | Janssen Pharmaceuticals, Inc ($29.88) |
| 2019 | $793.45 | 5 | PFIZER INC. ($571.48) |
| 2018 | $441.24 | 7 | E.R. Squibb & Sons, L.L.C. ($218.19) |
| 2017 | $211.46 | 5 | E.R. Squibb & Sons, L.L.C. ($211.46) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HIV | ||||||
| 02/07/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $132.63 | General |
| Category: Cardiovascular | ||||||
| 11/22/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $126.98 | General |
| Category: Cardiovascular | ||||||
| 10/18/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Cardiovascular | ||||||
| 07/18/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.91 | General |
| Category: Cardiovascular | ||||||
| 11/10/2021 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $112.68 | General |
| 04/20/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/29/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $29.88 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/15/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $100.01 | General |
| Category: Cardiovascular | ||||||
| 07/19/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/18/2019 | PFIZER INC. | ELIQUIS (Drug) | Consulting Fee | Cash or cash equivalent | $425.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/25/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $134.39 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/10/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $121.96 | General |
| Category: Cardiovascular | ||||||
| 11/29/2018 | DePuy Synthes Sales Inc. | ORTHOVISC (Device), MONOVISC | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Sports Early Intervention | ||||||
| 11/27/2018 | DePuy Synthes Sales Inc. | ORTHOVISC (Device), MONOVISC | Food and Beverage | In-kind items and services | $84.40 | General |
| Category: Sports Early Intervention | ||||||
| 07/26/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $124.97 | General |
| Category: Cardiovascular | ||||||
| 05/16/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/16/2018 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/16/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.46 | General |
| Category: Cardiovascular | ||||||
| 01/11/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $75.76 | General |
| Category: Cardiovascular | ||||||
| 10/30/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.56 | General |
| Category: Cardiovascular | ||||||
| 10/24/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $60.82 | General |
| Category: Cardiovascular | ||||||
| 08/22/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $96.43 | General |
| Category: Cardiovascular | ||||||
| 08/21/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.67 | General |
| Category: Cardiovascular | ||||||
| 02/06/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.98 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 128 | 260 | $48,173 | $20,909 |
| 2022 | 4 | 164 | 289 | $57,571 | $22,915 |
| 2021 | 3 | 150 | 288 | $54,891 | $22,516 |
| 2020 | 4 | 134 | 196 | $44,633 | $17,927 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 50 | 145 | $22,910 | $9,417 | 41.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 36 | 73 | $16,863 | $7,415 | 44.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 42 | 42 | $8,400 | $4,077 | 48.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 50 | 135 | $21,330 | $8,008 | 37.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 52 | 90 | $20,790 | $7,951 | 38.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 51 | 53 | $10,600 | $5,038 | 47.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 11 | 11 | $4,851 | $1,917 | 39.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 54 | 105 | $24,255 | $9,625 | 39.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 56 | 142 | $22,436 | $8,999 | 40.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 40 | 41 | $8,200 | $3,892 | 47.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 33 | 33 | $14,553 | $5,813 | 39.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 38 | 91 | $14,378 | $5,572 | 38.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 33 | 42 | $9,702 | $3,743 | 38.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 30 | 30 | $6,000 | $2,798 | 46.6% |
About Dr. Ryan Punsalan, M.D
Dr. Ryan Punsalan, M.D is a Internal Medicine healthcare provider based in Middletown, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2012. The National Provider Identifier (NPI) number assigned to this provider is 1871852350.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Punsalan, M.D has received a total of $2,135 in payments from pharmaceutical and medical device companies, with $125.00 received in 2024. These payments were reported across 25 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($1,710).
As a Medicare-enrolled provider, Punsalan has provided services to 576 Medicare beneficiaries, totaling 1,033 services with total Medicare billing of $84,267. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist
- Location Middletown, NY
- Active Since 05/03/2012
- Last Updated 11/27/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1871852350
Products in Payments
- ELIQUIS (Drug) $1,483
- CAMZYOS (Drug) $141.91
- APRETUDE (Biological) $125.00
- ORTHOVISC (Device) $103.53
- ENTRESTO (Drug) $100.00
- XARELTO (Drug) $49.54
- TEFLARO (Drug) $19.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Middletown
Dr. Zainab Mogul-Ashraf, M.d, M.D
Internal Medicine — Payments: $190,519
Taraneh Soleymani, M.d, M.D
Internal Medicine — Payments: $165,396
Dr. John Ferguson, M.d, M.D
Internal Medicine — Payments: $22,796
Sabena Ramsetty
Internal Medicine — Payments: $19,117
Alexander Fruchter, Md, MD
Internal Medicine — Payments: $15,642
Dr. Angelo Paredes, M.d, M.D
Internal Medicine — Payments: $12,442